Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Drygiannakis

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and FibrosisMichail Spathakis, Nikolas Dovrolis, Eirini Filidou, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial MyofibroblastsGesthimani Tarapatzi, Eirini Filidou, Leonidas Kandilogiannakis, et al.
Biomedicines|August 29, 2024
Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2Nikolas Dovrolis, Vassilis Valatas, Ioannis Drygiannakis, et al.
Inflammatory Bowel Diseases|May 8, 2024
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial MyofibroblastsGeorgios Kokkotis, Eirini Filidou, Gesthimani Tarapatzi, et al.
Frontiers in Immunology|January 12, 2023
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?Nikolas Dovrolis, Eirini Filidou, Gesthimani Tarapatzi, et al.
Annals of Gastroenterology|March 24, 2025
Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL studyJohn Koskinas, Spyridon Pantzios, Melanie Deutsch, et al.
European Journal of Gastroenterology & Hepatology|April 12, 2019
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in GreeceNikos Viazis, Christos Pontas, Konstantinos Karmiris, et al.
World Journal of Gastroenterology|November 24, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up studyMaria Tzouvala, Eirini Zacharopoulou, Maria Kalafateli, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative studyNikos Viazis, Murat Toruner, Vasilios Papastergiou, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and FibrosisMichail Spathakis, Nikolas Dovrolis, Eirini Filidou, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial MyofibroblastsGesthimani Tarapatzi, Eirini Filidou, Leonidas Kandilogiannakis, et al.
Biomedicines|August 29, 2024
Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2Nikolas Dovrolis, Vassilis Valatas, Ioannis Drygiannakis, et al.
Inflammatory Bowel Diseases|May 8, 2024
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial MyofibroblastsGeorgios Kokkotis, Eirini Filidou, Gesthimani Tarapatzi, et al.
Frontiers in Immunology|January 12, 2023
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?Nikolas Dovrolis, Eirini Filidou, Gesthimani Tarapatzi, et al.
Annals of Gastroenterology|March 24, 2025
Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL studyJohn Koskinas, Spyridon Pantzios, Melanie Deutsch, et al.
European Journal of Gastroenterology & Hepatology|April 12, 2019
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in GreeceNikos Viazis, Christos Pontas, Konstantinos Karmiris, et al.
World Journal of Gastroenterology|November 24, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up studyMaria Tzouvala, Eirini Zacharopoulou, Maria Kalafateli, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative studyNikos Viazis, Murat Toruner, Vasilios Papastergiou, et al.
Pageof 4